SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-19-023682
Filing Date
2019-04-25
Accepted
2019-04-25 16:05:27
Documents
5
Effectiveness Date
2019-04-25

Document Format Files

Seq Description Document Type Size
1 DEFA14A a19-8546_4defa14a.htm DEFA14A 33359
2 GRAPHIC g85464bei001.gif GRAPHIC 130101
3 GRAPHIC g85464bei002.gif GRAPHIC 102904
4 GRAPHIC g85464bei003.gif GRAPHIC 57875
5 GRAPHIC g85464bei004.gif GRAPHIC 54413
  Complete submission text file 0001104659-19-023682.txt   510434
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33451 | Film No.: 19767437
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1